Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-011985

Options or other derivatives

  • CHIEF ACCOUNTING OFFICER acquired 17,444 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Megna Michael R CHIEF ACCOUNTING OFFICER 2025-05-01 Grant or award · Performance Share Unit +3,270 3,270 D
Megna Michael R CHIEF ACCOUNTING OFFICER 2025-05-01 Grant or award · Performance Share Unit +3,433 3,433 D
Megna Michael R CHIEF ACCOUNTING OFFICER 2025-05-01 Grant or award · Performance Share Option +5,285 5,285 D
Megna Michael R CHIEF ACCOUNTING OFFICER 2025-05-01 Grant or award · Performance Share Option +5,456 5,456 D
Loading xslF345X05/form4-05052025_080516.xml…